Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
								
																		
									
										
											Công thức hóa học
										
										
											
																						C22H26N2O4																					
									 
																											
																		
									
																											
																		
									
										
											Monoisotopic mass 
										
										
											382.18925733										
									 
																											
									
																		
									
										
											InChI 
										
										
											InChI=1S/C22H26N2O4/c1-7-15-13(2)23-24-22(14-8-9-18(25-3)19(10-14)26-4)17-12-21(28-6)20(27-5)11-16(15)17/h8-12,15H,7H2,1-6H3										
									 
																		
																		
										
											InChI Key 
										
										
											InChIKey=RUJBDQSFYCKFAA-UHFFFAOYSA-N										
									 
																											
																		
										
											IUPAC Name 
										
										
											1-(3,4-dimethoxyphenyl)-5-ethyl-7,8-dimethoxy-4-methyl-5H-2,3-benzodiazepine										
									 
																											
																		
										
											Traditional IUPAC Name 
										
										
											tofisopam										
									 
																											
									
																		
										
											SMILES 
										
										
											CCC1C2=CC(OC)=C(OC)C=C2C(=NN=C1C)C1=CC(OC)=C(OC)C=C1										
									 
																		
																		
									
																		
																		
																		
																		
																		
																											
																		
																											
																		
																											
																		
																		
										
											pKa (Strongest Basic) 
										
										
											-2.2										
									 
																											
																		
																											
																		
										
											Refractivity 
										
										
											109.03 m3·mol-1
										
									 
																			  
		  
																		
																											
																		
																		
									
																		
																		
																		
																		
																		
																		
																		
																		
																		
											  
		  
								 
							 	
														
															
								 Dược Lực Học : 
								
									Like other benzodiazepines, tofisopam possesses anxiolytic properties but unlike other benzodiazepines it does not have anticonvulsant, sedative, skeletal muscle relaxant, motor skill-impairing or amnestic properties. While it may not be an anticonvulsant in and of itself, it has been shown to enhance the anticonvulsant action of classical 1,4-benzodiazepines such as diazepam (but not sodium valproate, carbamazepine, phenobarbital, or phenytoin).									
							
														
															
								 Cơ Chế Tác Dụng : 
								
									Tofisopam (marketed under brand names Emandaxin and Grandaxin) is a 2,3-benzodiazepine drug which is a benzodiazepine derivative. In contrast to classical 1,4-benzodiazepines, the compound does not bind to the benzodiazepine binding site of the gamma-aminobutyric acid receptor and its psychopharmacological profile differs from such compounds. Although Tofisopam is not approved for sale in North America, it is approved for use in various countries worldwide, including parts of Europe. The D-enantiomer (dextofisopam) is currently in phase II trials in the U.S. for the treatment of irritable bowel syndrome.								
								
									Tofisopam does not bind to the benzodiazepine binding site of the gamma-aminobutyric acid receptor. One study (Rundfeldt C. et al.) has shown that tofisopam acts as an isoenzyme-selective inhibitor of phosphodiesterases (PDEs) with highest affinity to PDE-4A1 (0.42 μM) followed by PDE-10A1 (0.92 μM), PDE-3 (1.98 μM) and PDE-2A3 (2.11 μM).								
							
														
															
								 Dược Động Học  : 
								
									
▧ Metabolism : 
Hepatic.
▧ Half Life : 
6-8 hours								
	
							 
														
														
								 Độc Tính : 
								
									The onset of impairment of consciousness is relatively rapid in benzodiazepine poisoning. Onset is more rapid following larger doses and with agents of shorter duration of action. The most common and initial symptom is somnolence. This may progress to coma (Grade I or Grade II) following very large ingestions. Oral, rat LD50 is 825 mg/kg.									
							
														
							
																					
								 Chỉ Định : 
								
									For the treatment of anxiety and alcohol withdrawal.